Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine: Results from the TANDEM Trial

被引：0
|
作者：
Ailani, Jessica [1 ]
Lipton, Richard B. [2 ]
Blumenfeld, Andrew M. [3 ]
He, Molly Yizeng [4 ]
Smith, Jonathan H. [5 ]
Trugman, Joel M. [4 ]
Ferreira, Rosa de Abreu [4 ]
Brand-Schieber, Elimor [4 ]
机构：
[1] Georgetown Univ Hosp, Washington, DC 20007 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Headache Ctr Southern Calif, Carlsbad, CA USA
[4] AbbVie, Madison, NJ 07940 USA
[5] AbbVie, N Chicago, IL USA
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-LBAP
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study
    Ailani, Jessica
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Klein, Brad C.
    He, Molly Yizeng
    Smith, Jonathan H.
    Trugman, Joel M.
    Ferreira, Rosa de Abreu
    Brand-Schieber, Elimor
    HEADACHE, 2024,
  • [2] Atogepant for the Preventive Treatment of Migraine Among Participants With Episodic Migraine With Prior Treatment Failure: Results From the ELEVATE Trial
    Pozo-Rosich, P.
    Nagy, K.
    Tassorelli, C.
    Lanteri-Minet, M.
    Sacco, S.
    Nezadal, T.
    Finnegan, M.
    Guo, H.
    Ferreira, De Abreu R.
    Trugman, J.
    HEADACHE, 2023, 63 : 117 - 117
  • [3] Atogepant for the Preventive Treatment of Migraine Among Participants With Episodic Migraine With Prior Treatment Failure: Results From the ELEVATE Trial
    Pozo-Rosich, Patricia
    Nagy, Krisztian
    Tassorelli, Cristina
    Lanteri-Minet, Michel
    Sacco, Sara
    Nezadal, Tomas
    Finnegan, Michelle
    Guo, Hua
    Ferreira, Rosa De Abreu
    Trugman, Joel M.
    CEPHALALGIA, 2023, 43 (1supp) : 47 - 49
  • [4] Atogepant for the Preventive Treatment of Migraine in Participants With Prior Treatment Failure: The ELEVATE Trial
    Pozo-Rosich, P.
    Nagy, K.
    Tassorelli, C.
    Lanteri-Minet, M.
    Sacco, S.
    Nezadal, T.
    Finnegan, M.
    Guo, H.
    Gandhi, P.
    Trugman, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 212 - 213
  • [5] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF UBROGEPANT FOR THE ACUTE TREATMENT OF MIGRAINE FOLLOWING COADMINISTRATION WITH PREVENTIVE MONOCLONAL ANTIBODY TREATMENT
    Jakate, Abhijeet
    Blumenfeld, Andrew M.
    Boinpally, Ramesh
    Butler, Matthew
    Borbridge, Lisa
    Contreras-De lama, Janette
    McGeeney, Danielle
    Periclou, Antonia
    Lipton, Richard B.
    CEPHALALGIA, 2020, 40 : 46 - 47
  • [6] Pharmacokinetics, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine Following Coadministration With Preventive Monoclonal Antibody Treatment
    Jakate, Abhijeet
    Blumenfeld, Andrew M.
    Boinpally, Ramesh
    Butler, Matthew
    Borbridge, Lisa
    lama, Janette Contreras-De
    McGeeney, Danielle
    Periclou, Antonia
    Lipton, Richard B.
    NEUROLOGY, 2021, 96 (15)
  • [7] Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine Following Co-Administration With Preventive Monoclonal Antibody Treatment
    Jakate, A.
    Boinpally, R.
    Butler, M.
    Borbridge, L.
    Contreras-De Lama, J.
    McGeeney, D.
    Periclou, A.
    HEADACHE, 2020, 60 : 124 - 124
  • [8] Atogepant for the Preventive Treatment of Migraine
    Ailani, Jessica
    Lipton, Richard B.
    Goadsby, Peter J.
    Guo, Hua
    Miceli, Rosa
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 695 - 706
  • [9] Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial
    Klein, Brad C.
    Miceli, Rosa
    Severt, Lawrence
    McAllister, Peter
    Mechtler, Laszlo
    McVige, Jennifer
    Diamond, Merle
    Marmura, Michael J.
    Guo, Hua
    Finnegan, Michelle
    Trugman, Joel M.
    CEPHALALGIA, 2023, 43 (01)
  • [10] Atogepant for the preventive treatment of chronic migraine: Results from the PROGRESS phase 3 trial
    Pozo-Rosich, P.
    Goadsby, P. J.
    HEADACHE, 2022, 62 (07): : 923 - 923
12345